Association of major histocompatibility complex class 1 chain-related gene A dimorphism with type 1 diabetes and latent autoimmune diabetes in adults in the Algerian population

Clinical and Vaccine Immunology

Volumn 19, Issue 4, 2012, Pages 557-561

  Raache, Rachida ^a,b   Belanteur, Khadidja ^b   Amroun, Habiba ^b   Benyahia, Amel ^c   Heniche, Amel ^b   Azzouz, Malha ^d   Mimouni, Safia ^d   Gervais, Thibaud ^e   Latinne, Dominique ^e   Boudiba, Aissa ^d   Attal, Nabila ^b   Abbadi, Mohamed Cherif ^b  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Institut Pasteur d'Algerie   (Algeria)

^c CHU N=Fissa Hamoud   (Algeria)

^d CHU Mustapha   (Algeria)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; METHIONINE; NATURAL KILLER CELL RECEPTOR NKG2D; VALINE;

ADOLESCENT; ADULT; ALGERIA; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS 1 CHAIN RELATED GENE A; MALE; MOLECULAR PATHOLOGY; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ALGERIA; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84859318044     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05473-11     Document Type: Article

References (42)

1. Alizadeh BZ, et al. 2007. MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis. Mol. Immunol. 44:2806-2812. (Pubitemid 46412504)
2. Amroun H, et al. 2005. Early-onset ankylosing spondylitis is associated with a functional MICA polymorphism. Hum. Immunol. 66:1057-1061. (Pubitemid 43005008)
3. Aquino-Galvez AM, et al. 2009. MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Hum. Genet. 125:639-648.
4. Bahram S, et al. 2005. MIC and other NKG2D ligands: from none to too many. Curr. Opin. Immunol. 17:505-509. (Pubitemid 41207954)
5. Baham S, et al. 1994. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. U. S. A. 91:6259-6263.
6. Bonifacio E, et al. 1990. Quantification of islet cell antibodies and prediction of insulin dependent diabetes. Lancet 335:147-149. (Pubitemid 20032735)
7. Borchers AT, Uibo R, Gershwin ME. 2010. The geoepidemiology of type 1 diabetes. Autoimmun. Rev. 9:A355-A365.
8. Borrego F, et al. 2002. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells. Mol. Immunol. 38:637-660. (Pubitemid 34168194)
9. Boukouaci W. 2009. MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease. Blood 114: 5216-5224.
10. Caillat-Zucman S. 2006. How NKG2D ligands trigger autoimmunity? Hum. Immunol. 67:204-207. (Pubitemid 43673924)
11. Concannon P, et al. 2009. Genetics of type 1A diabetes. N. Engl. J. Med. 360:1646-1654.
12. Csorba TR, et al. 2010. Autoimmunity and the pathogenesis of type 1 diabetes. Crit. Rev. Clin. Lab. Sci. 47:51-71.
13. Cucca F, et al. 1993. Combinations of specific DRB1, DQA1, and DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum. Immunol. 37:85-94. (Pubitemid 23259993)
14. Douik H, et al. 2009. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population. Hum. Immunol. 70:45-48.
15. Frigoul A, Lefranc MP. 2005. MICA: standardized IMGT allele nomenclature, polymorphisms and diseases. Recent Res. Devel. Hum. Genet. 3:95-145.
16. Gambelunghe G, et al. 2001. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J. Clin. Endocrinol. Metab. 86: 3754-3760. (Pubitemid 32755972)
17. Gambelunghe G, et al. 2007. MICA gene polymorphism: the pathogenesis of type 1 diabetes. Ann. N. Y. Acad. Sci. 1110:92-98. (Pubitemid 350042999)
18. Groh V, et al. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Nati. Acad. Sci., U. S. A. 93:12445-12450. (Pubitemid 26367163)
19. Groh V, et al. 2003. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 100:9452-9457. (Pubitemid 37033949)
20. Groop L, et al. 1986. Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241. (Pubitemid 16121546)
21. Gupta ML, et al. 2003. Association between the transmembrane region polymorphism of MHC class I chain related gene-A and type 1 diabetes mellitus in Sweden. Hum. Immunol. 64:553-561.
22. Hue S, et al. 2004. Direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21:367-377. (Pubitemid 39208338)
23. Lopez-Hernandez R, et al. 2010. Association analysis of MICA gene polymorphism and MICA-129 dimorphism with inflammatory bowel disease susceptibility in a Spanish population. Hum. Immunol. 71:512-514.
24. Ludvigsson JU. 1986. HLA-DR3 is associated with a more slowly progressive form of type 1 (insulin-dependent) diabetes. Diabetologia 29:207-221.
25. Mizuki N, et al. 1997. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc. Natl. Acad. Sci. U. S. A. 94:1298-1303.
26. Morran MP, et al. 2008. Immunology and genetics of type 1 diabetes. Mt. Sinai J. Med. 75:314-327.
27. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1042.
28. Ogasawara K, et al. 2004. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20:757-767. (Pubitemid 38757445)
29. Park Y, et al. 2001. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 24:33-38. (Pubitemid 32104216)
30. Radtke MA, et al. 2009. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment. Diabetes Care 32:245-250.
31. Sanjeevi CB. 2006. Genes influencing innate and acquired immunity in type 1 diabetes and latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 1079:67-80. (Pubitemid 44968703)
32. Stastny P. 2006. Introduction: MICA/MICB in innate immunity, adaptative immunity, autoimmunity, cancer, and in the immune response to transplants. Hum. Immunol. 67:141-144.
33. Steinle A, et al. 2001. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 53:279.
34. Tonnerre P, et al. 2010. MICA gene polymorphism in kidney allografts and possible impact of functionally relevant variants. Transplant. Proc. 42:4318-4321.
35. Torn C, et al. 2003. Heterozygosity for MICA5.0/MICA5.1 and HLADR3- DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum. Immunol. 64:902-909. (Pubitemid 37093463)
36. Triolo TM, et al. 2009. Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes J. Clin. Endocrinol. Metab. 94:1210-1308.
37. + T cells in type 1 diabetes. Adv. Immunol. 100:79-124.
38. Van Autreve JE, et al. 2006. MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum. Immunol. 67:94-101.
39. van Deutekom AW, et al. 2008. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet. Med. 25:117-125.
40. von Herrath M, et al. 2007. Type 1 diabetes as a relapsing-remitting disease? Nat. Rev. Immunol. 7:988-994.
41. Zhao J, et al. 2011. Functional MICA-129 Polymorphism and serum levels of soluble MICA are correlated with ulcerative colitis in Chinese patients. J. Gastroenterol. Hepatol. 26:593-598.
42. Zwirner NW, et al. 1998. MICA, a new polymorphic HLA related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 47:139-148. (Pubitemid 28059537)